Jalazolam Plus Tablet is a combination pharmaceutical formulation containing Etizolam 0.5 mg and Escitalopram Oxalate 10 mg, designed for the management of anxiety disorders and depressive symptoms. Etizolam, a thienodiazepine derivative, acts as a short-acting anxiolytic with sedative, muscle relaxant, and anticonvulsant properties by modulating the gamma-aminobutyric acid (GABA) neurotransmitter system, thereby producing a calming effect on the central nervous system. Escitalopram Oxalate, a selective serotonin reuptake inhibitor (SSRI), enhances serotonergic neurotransmission by inhibiting serotonin reuptake in the presynaptic neuron, which helps alleviate symptoms of depression and anxiety. The synergistic action of these two active ingredients provides effective relief from generalized anxiety disorder, panic disorder, and major depressive disorder, improving patient quality of life. Jalazolam Plus is typically prescribed under medical supervision, with dosage individualized based on clinical response and tolerability. Caution is advised in patients with a history of substance abuse, hepatic or renal impairment, and concurrent use of other central nervous system depressants. Common side effects may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances. Patients should avoid alcohol and operating heavy machinery while on this medication. Regular follow-up is recommended to monitor therapeutic efficacy and adverse effects.